Elisabeth Gentry, 22 and seizure-free, is now driving, working as a full-time nanny, and living independently after her treatment and surgery at UTHealth Houston. Elisabeth Gentry had experienced auras ever since she was a toddler, but she didn’t learn that the occasional strange tastes in her mouth and feelings of impending doom were epilepsy until […]
Soticlestat, a small molecule that inhibits the activity of cholesterol 24-hydroxylase, one of several enzymes responsible for catabolism of cholesterol, has the potential to translate into a useful therapy for epilepsy, but more research from clinical trials are needed, experts said. A compound that inhibits cholesterol catabolism has potential as an antiseizure drug, according to […]
Tuesday 7:00 PM July 12th, 2022 Join Zoom Meeting https://us02web.zoom.us/j/5055488222
Differences in the connectivity of different regions of the hippocampus could predict which patients with epilepsy would not suffer impairments in verbal learning after surgery, and therefore, could benefit from it. This is the main discovery of a study by the Cognition and Brain Plasticity research group at IDIBELL, the Bellvitge University Hospital, and the […]
When Aarti Sathyanarayana shadowed a neurologist at Boston Children’s Hospital, it sparked an idea that could change how doctors treat epilepsy. Sathyanarayana saw how doctors were evaluating whether they’d picked the right medication for epilepsy in a patient. It’s largely a trial-and-error approach, she says. The doctor will prescribe medication and then the patient will return […]
The University of Utah College of Pharmacy’s Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $34 million contract renewal with the NIH’s National Institute of Neurological Disorders and Stroke (NINDS) to test and identify novel investigational therapeutics for preventing the development of epilepsy and treating refractory, or drug-resistant, epilepsy. Epilepsy is the fourth most […]
